My Malignant Melanoma
Seanty's experiences with Metastatic Malignant Melanoma. Part of www.mymalignantmelanoma.com. Email us direct at help@mymalignantmelanoma.comWednesday, 11 November 2009
BRAF Mutations and AZD6244
There's a paper in the British Journal of Cancer showing success in detecting BRAF mutations via blood samples instead of tumour biopsies.
The presence of these mutations is the basis for treatment with PLX4032, as well as the drug in this trial, AZD6244, though the two drugs work in different ways.
I see there is an open clinical trial of AZD6244 in Oxford, and that the BJC paper is authored by people at Christie's.
The presence of these mutations is the basis for treatment with PLX4032, as well as the drug in this trial, AZD6244, though the two drugs work in different ways.
I see there is an open clinical trial of AZD6244 in Oxford, and that the BJC paper is authored by people at Christie's.
Labels: AZD6244, BRAF, PLX4032
Archives
August 2008 September 2008 October 2008 November 2008 December 2008 January 2009 February 2009 April 2009 May 2009 June 2009 July 2009 August 2009 September 2009 October 2009 November 2009 December 2009 January 2010 February 2010 March 2010
Subscribe to Posts [Atom]